HOXB13 mutation and prostate cancer: Studies of siblings and aggressive disease

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 4, 2013, Pages 675-680

  Witte, John S ^a   Mefford, Joel ^a   Plummer, Sarah J ^b   Liu, Jinghua ^a   Cheng, Iona ^c   Klein, Eric A ^d   Rybicki, Benjamin A ^e   Casey, Graham ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^d TAUSSIG CANCER INSTITUTE   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEOBOX B13; HOMEODOMAIN PROTEIN; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; CASE CONTROL STUDY; CHROMOSOME; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HAPLOTYPE; HOMEOBOX; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; ONSET AGE; PRIORITY JOURNAL; PROSTATE CANCER; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DNA; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM GRADING; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; RISK FACTORS; SIBLINGS;

EID: 84876547982     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1154     Document Type: Article

References (26)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36.
2. Witte JS. Genome-wide association studies and beyond. Annu Rev Public Health 2010;31:9-20.
3. Witte JS. Prostate cancer genomics: towards a new understanding. Nat Rev Genet 2009;10:77-82.
4. Lange EM, Gillanders EM, Davis CC, Brown WM, Campbell JK, Jones M, et al. Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. Prostate 2003;57:326-34. (Pubitemid 37487078)
5. Gillanders EM, Xu J, Chang BL, Lange EM, Wiklund F, Bailey-Wilson JE, et al. Combined genome-wide scan for prostate cancer susceptibility genes. J Natl Cancer Inst 2004;96:1240-7. (Pubitemid 39232715)
6. Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005;77:219-29. (Pubitemid 41022705)
7. Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, Tembe WD, et al. Germline mutations inHOXB13 and prostate-cancer risk.NEngl J Med 2012;366:141-9.
8. Breyer JP, Avritt TG, McReynolds KM, Dupont WD, Smith JR. Confirmation of the HOXB13 G84E Germline Mutation in Familial Prostate Cancer. Cancer Epidemiol Biomarkers Prev 2012;21:1348-53.
9. Akbari MR, Trachtenberg J, Lee J, Tam S, Bristow R, Loblaw A, et al. Association between germline HOXB13 G84E mutation and risk of prostate cancer. J Natl Cancer Inst 2012;104:1260-2.
10. Karlsson R, Aly M, Clements M, Zheng L, Adolfsson J, Xu J, et al. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk. Eur Urol 2012 Jul 20. [Epub ahead of print].
11. Lin X,Qu L, Chen Z, Xu C, Ye D, Shao Q, et al.Anovel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men. Prostate 2013;73:169-75.
12. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 2002;32:581-3. (Pubitemid 35435169)
13. Cheng I, Plummer SJ, Neslund-Dudas C, Klein EA, Casey G, Rybicki BA, et al. Prostate cancer susceptibility variants confer increased risk of disease progression. Cancer Epidemiol Biomarkers Prev 2010; 19:2124-32.
14. Price AL, Tandon A, Patterson N, Barnes KC, Rafaels N, Ruczinski I, et al. Sensitive detection of chromosomal segments of distinct ancestry in admixed populations. PLoS Genet 2009;5:e1000519.
15. HapMap. The International HapMap Project. Nature 2003;426:789-96.
16. 1000 Genomes Project Consortium Durbin RM, Abecasis GR, Altshuler DL, Auton A, Brooks LD, et al. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-73.
17. Barry M. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:2674.
18. Salmela E, Lappalainen T, Liu J, Sistonen P, Andersen PM, Schreiber S, et al. Swedish population substructure revealed by genome-wide single nucleotide polymorphism data. PLoS One 2011;6:e16747.
19. Alanee S, Couch F, Offit K. Association of aHOXB13variant with breast cancer. N Engl J Med 2012;367:480-1.
20. Graham A. Developmental patterning. The Hox code out on a limb. Curr Biol 1994;4:1135-7. (Pubitemid 124001604)
21. Goodman FR, Scambler PJ. Human HOX gene mutations. Clin Genet 2001;59:1-11. (Pubitemid 32049120)
22. Kim YR, Oh KJ, Park RY, Xuan NT, Kang TW, Kwon DD, et al. HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling. Mol Cancer 2010;9:124.
23. Jung C, Kim RS, Zhang HJ, Lee SJ, Jeng MH. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormoneactivated androgen receptor signaling. Cancer Res 2004;64:9185-92. (Pubitemid 39665535)
24. Norris JD, Chang CY, Wittmann BM, Kunder RS, Cui H, Fan D, et al. The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol Cell 2009;36:405-16.
25. Kim SD, Park RY, Kim YR, Kim IJ, Kang TW, Nam KI, et al. HOXB13 is co-localized with androgen receptor to suppress androgen-stimulated prostate-specific antigen expression. Anat Cell Biol 2010;43:284-93.
26. Jung C, Kim RS, Lee SJ, Wang C, Jeng MH. HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4. Cancer Res 2004;64:3046-51. (Pubitemid 38581403)